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183 Preoperative Sinonasal Symptom Scores PredictPost-Surgery, Post-Aspirin Desensitization
Disease Status in Aspirin Exacerbated
Respiratory Disease
Edward C. Kuan, MD1, William P. Kennedy, MD2, Neil N. Patel, BS2, 
Michael A. Kohanski, MD, PhD2, Charles C. Tong, MD2, David W. 
Kennedy, MD2, James Palmer, MD2, Nithin D. Adappa, MD2, and John 
V. Bosso3; 1UC Irvine, Orange, CA, 2University of Pennsylvania, Phila-
delphia, PA, 3Department of OtorhinolaryngologydHead and Neck Sur-
gery, Division of Rhinology, University of Pennsylvania, Perelman School 
of Medicine, Philadelphia, PA.
RATIONALE: Aspirin exacerbated respiratory disease (AERD) is a 
challenging upper and lower respiratory disease which requires joint 
management between allergists and otolaryngologists. Complete sinus 
surgery followed by aspirin desensitization (AD) appears to improve 
outcomes long-term. Recent studies have demonstrated a relationship 
between high preoperative, pre-AD sinonasal symptoms scores and 
severity of reactions during AD. In this study, we provide the first evidence 
for using stratified preoperative, pre-AD sinonasal symptom scores to 
predict postoperative, post-AD outcomes.
METHODS: Retrospective chart review of all patients with aspirin 
challenge-proven AERD who underwent complete endoscopic sinus 
surgery followed by AD. Preoperative, postoperative/pre-AD, and short-
(<2 months) and long-term (>6 months) postoperative/post-AD sinonasal 
symptom scores were collected (22-item Sino-Nasal Outcomes Test, 
SNOT-22). A longitudinal linear mixed-effects model was used for data 
analysis.
RESULTS: Preoperative SNOT-22 scores (n547) were divided into 
tertiles (cutoffs of 36 and 54 indicating mild [22.5613.7], moderate 
[44.3612.2], and severe [72.9619.7] disease). Postoperative, pre-AD 
SNOT-22 in all disease groups decreased and were not significantly 
different (12.3613.7, 11.1612.2, and 22.7619.7; p50.074). Following 
AD, only the severe group scores worsened (35.0620.3, p<0.001), 
whereas the other groups demonstrated negligible change (9.3614.3 and 
14.4612.2). At 6 months post-AD, all groups redemonstrated convergence 
in symptom scores (23.7620.9, 19.4615.4, and 31.0627.6, p50.304). 
CONCLUSIONS: Preoperative SNOT-22 scores may be used as a 
predictor of postoperative, post-AD patient-reported outcomes in AERD. 
Patients with mild and moderate disease may derive benefit from AD alone, 
while those with severe disease may require additional interventions (e.g., 
biologics).
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